Angiogenesis Research Center

BIDMC/Harvard Medical School

The Angiogenesis Research Center at the Beth Israel Deaconess Medical Center and Harvard Medical School provides cutting edge investigational treatment strategies for patients with ischemic heart disease and peripheral vascular disease, performs pre-clinical studies of promising new technologies, and carries out basic science research to better understand the underlying mechanisms of cardiovascular disease.

Click for Case of the week

News:

Structural Heart Center offers novel therapies for high risk patients

Study supported by Center for Integration of Medicine and Innovative Technology Award shows tremendeous promise for myocardial regeneration after myocardial infarction (Circulation 2011)

Center studies vulnerable plaque imaging in an effort to detect heart attacks before they happen. PET/CT with special protocols was used to detect plaque inflammation. This is promising for screening high risk subgroups.

Center establishes a novel preclinical model for high throughput stent development and delivery modalities enabling proof of concept and principal within months rather than years (J Pharm Biomed Anal. 2011, J Surg Res. 2010, J Biomed Mater Res A. 2011)

Center establishes a key protective role of exercise in myocardial ischemia and infarction and its beneficial effect on angiogenesis

Proof of concept established for several innovative devices to treat Cardiovascular disease

High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction Without Improving the Angiogenic Response

Angiogenesis and Direct Myocardial Revascularization textbook is a comprehensive discussion of the state of the science and the hurdles that must be overcome to achieve successful angiogenesis/myogenesis